Literature DB >> 16061847

Multiple mechanisms of telomere maintenance exist in liposarcomas.

Jay E Johnson1, Robert J Varkonyi, Jaclyn Schwalm, Ryan Cragle, Andres Klein-Szanto, Arthur Patchefsky, Edna Cukierman, Margaret von Mehren, Dominique Broccoli.   

Abstract

PURPOSE: Telomeres are specialized nucleoprotein complexes that protect and confer stability upon chromosome ends. Loss of telomere function as a consequence of proliferation-associated sequence attrition results in genome instability, which may facilitate carcinogenesis by generating growth-promoting mutations. However, unlimited cellular proliferation requires the maintenance of telomeric DNA; thus, the majority of tumor cells maintain their telomeres either through the activity of telomerase or via a mechanism known as alternative lengthening of telomeres (ALT). Recent data suggest that constitutive telomere maintenance may not be required in all tumor types. Here we assess the role and requirement of telomere maintenance in liposarcoma. EXPERIMENTAL
DESIGN: Tumor samples were analyzed with respect to telomerase activity, telomere length, and the presence of ALT-specific subcellular structures, ALT-associated promyelocytic leukemia nuclear bodies. This multi-assay assessment improved the accuracy of categorization.
RESULTS: Our data reveal a significant incidence (24%) of ALT-positive liposarcomas, whereas telomerase is used at a similar frequency (27%). A large number of tumors (49%) do not show characteristics of telomerase or ALT. In addition, telomere length was always shorter in recurrent disease, regardless of the telomere maintenance mechanism.
CONCLUSIONS: These results suggest that approximately one half of liposarcomas either employ a novel constitutively active telomere maintenance mechanism or lack such a mechanism. Analysis of recurrent tumors suggests that liposarcomas can develop despite limiting or undetectable activity of a constitutively active telomere maintenance mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061847     DOI: 10.1158/1078-0432.CCR-05-0684

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  22 in total

1.  Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas.

Authors:  Jen-Chieh Lee; Yung-Ming Jeng; Jau-Yu Liau; Jia-Huei Tsai; Hung-Han Hsu; Ching-Yao Yang
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

2.  Doxorubicin resistance in a novel in vitro model of human pleomorphic liposarcoma associated with alternative lengthening of telomeres.

Authors:  Marcy A Mitchell; Jay E Johnson; Kara Pascarelli; Neil Beeharry; Maria Chiourea; Sarantis Gagos; Dina Lev; Margaret von Mehren; David Kipling; Dominique Broccoli
Journal:  Mol Cancer Ther       Date:  2010-03-02       Impact factor: 6.261

3.  Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance.

Authors:  Lorenza Venturini; Maria Grazia Daidone; Rosita Motta; Graziella Cimino-Reale; Stacey F Hoare; Alessandro Gronchi; Marco Folini; William Nicol Keith; Nadia Zaffaroni
Journal:  Neuro Oncol       Date:  2012-04-19       Impact factor: 12.300

Review 4.  Alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.

Authors:  Xiaolei Ren; Chao Tu; Zhenchu Tang; Ruofei Ma; Zhihong Li
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

5.  Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis.

Authors:  Lorenza Venturini; Rosita Motta; Alessandro Gronchi; MariaGrazia Daidone; Nadia Zaffaroni
Journal:  BMC Cancer       Date:  2010-06-03       Impact factor: 4.430

6.  ALTernative Telomere Maintenance and Cancer.

Authors:  Robert L Dilley; Roger A Greenberg
Journal:  Trends Cancer       Date:  2015-10-01

7.  Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.

Authors:  April R S Gocha; Gerard Nuovo; Obiajulu H Iwenofu; Joanna Groden
Journal:  Am J Pathol       Date:  2013-01       Impact factor: 4.307

8.  Multiple Mechanisms Contribute To Telomere Maintenance.

Authors:  Tammy A Morrish; Dulat Bekbolysnov; David Velliquette; Michelle Morgan; Bryan Ross; Yongheng Wang; Benjamin Chaney; Jessica McQuigg; Nathan Fager; Ira P Maine
Journal:  J Cancer Biol Res       Date:  2013-11-19

Review 9.  Human telomerase activity regulation.

Authors:  Aneta Wojtyla; Marta Gladych; Blazej Rubis
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

10.  A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT.

Authors:  K Lafferty-Whyte; C J Cairney; M B Will; N Serakinci; M-G Daidone; N Zaffaroni; A Bilsland; W N Keith
Journal:  Oncogene       Date:  2009-08-17       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.